封面
市場調查報告書
商品編碼
1673075

人工心臟瓣膜市場:依位置類型、依瓣膜類型、依最終用戶、按地區

Prosthetic Heart Valve Market, By Position Type, By Valve Type, By End User,, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球人工心臟瓣膜市場規模預計為 147.6 億美元,預計到 2032 年將達到 320.4 億美元,2025 年至 2032 年的複合年成長率為 11.7%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 147.6億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025 年至 2032 年複合年成長率 11.70% 2032 年金額預測 320.4億美元
數字。人工心臟瓣膜市場區域佔有率(%)(2025 年)
人工心臟瓣膜市場-IMG1

由於心臟瓣膜疾病發生率不斷上升以及瓣膜置換手術數量的增加,人工心臟瓣膜市場在過去幾年一直經歷穩定成長。人工心臟瓣膜有助於替換無法正常功能的受損心臟瓣膜。由於人口老化以及吸菸、肥胖、糖尿病等危險因素,二尖瓣瓣膜閉鎖不全、主動脈瓣瓣膜閉鎖不全、狹窄等心臟瓣膜疾病患者數量大幅增加。此外,從機械瓣膜到生物瓣膜的瓣膜設計技術進步以及醫療保健成本的增加正在促進全球人工心臟瓣膜市場的成長。然而,高昂的治療費用仍然是阻礙其廣泛應用的主要問題。

市場動態

主要國家老化人口的增加以及心臟瓣膜疾病負擔的增加是人工心臟瓣膜市場的主要成長動力。據估計,光在美國就有超過 1,600 萬人患有瓣膜疾病。肥胖和糖尿病的盛行率不斷上升,是市場發展的主要風險因素,同時也促進了市場的成長。此外,技術先進的微創經導管心臟瓣膜作為傳統開胸手術的替代方案,正在逐步引入,從而增加市場收益。然而,瓣膜置換手術的高昂費用限制了其廣泛應用,尤其是在開發中地區。嚴格的新產品核可監管準則也對市場產生了不利影響。然而,持續的研究和開發以開發價格實惠的設備和增強的技術將為未來幾年人工心臟瓣膜製造商帶來巨大的機會。

研究的主要特點

  • 本報告對全球人工心臟瓣膜市場進行了詳細分析,並提供了預測期(2025-2032)的市場規模和年複合成長率(CAGR%),以 2024 年為基準年。
  • 它還強調了各個領域的潛在收益成長機會,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
  • 全球人工心臟瓣膜市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球人工心臟瓣膜市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過全球人工心臟瓣膜市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件

第2章 市場概況

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 市場機會藍圖

第 3 章 關鍵見解

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • PEST分析
  • 波特分析
  • 技術進步
  • 併購與合作場景
  • 近期產品核可
  • 確定每個地區的主要參與企業
  • 監管情景
  • 定價分析
  • COVID-19影響分析
  • 流行病學
  • 國家醫療費用支出
  • 贖回情況
  • 經銷商狀況
  • 品牌地圖
  • 比賽概況
  • 公司定位分析
  • 熱圖分析

4. 全球人工心臟瓣膜市場,依地區類型,2020 年至 2032 年

  • 介紹
  • 主動脈瓣
  • 二尖瓣
  • 其他

5. 全球人工心臟瓣膜市場,依瓣膜類型,2020 年至 2032 年

  • 介紹
  • 機械閥
  • 組織瓣膜
  • 經導管瓣膜

6. 全球人工心臟瓣膜市場,依最終用戶分類,2020 年至 2032 年

  • 介紹
  • 醫院
  • 門診手術中心
  • 導管室
  • 其他

7. 2020 年至 2032 年全球人工心臟瓣膜市場(按地區)

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第8章 競爭格局

  • 衝突的簡介
  • 市場參與者的觀點
  • 競爭儀錶板
  • 2025 年公司市場佔有率分析 - 全球

9. 公司簡介-全球人工心臟瓣膜市場

  • Edwards Lifesciences Corporation
  • Medtronic plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova PLC
  • CryoLife Inc.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • JenaValve Technology Inc.
  • TTK Healthcare Limited
  • Lepu Medical Technology Co. Ltd
  • Foldax, Inc.
  • Symetis SA
  • On-X Life Technologies
  • Braile Biomedica

第 10 章 興衰

  • 興衰
  • 一致的機會地圖

第 11 章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI69

Global Prosthetic Heart Valve Market is estimated to be valued at USD 14.76 Bn in 2025 and is expected to reach USD 32.04 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 14.76 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.70% 2032 Value Projection: USD 32.04 Bn
Figure. Prosthetic Heart Valve Market Share (%), By Region 2025
Prosthetic Heart Valve Market - IMG1

The prosthetic heart valve market has been witnessing steady growth over the past few years owing to the increasing prevalence of heart valve diseases and rising number of valve replacement surgeries. Prosthetic heart valves help in replacing damaged heart valves that do not function properly. There has been a substantial increase in the patient pool suffering from heart valve conditions such as mitral and aortic regurgitation or stenosis due to aging population and risk factors like smoking, obesity, and diabetes. Moreover, technological advancements in valve design from mechanical valves to bioprosthetic valves and rising healthcare expenditure have been contributing towards the growth of the prosthetic heart valve market globally. However, high cost of treatment remains a key concern inhibiting wider adoption.

Market Dynamics:

Rising geriatric population base along with increasing burden of heart valve diseases across major countries act as the major growth drivers for the prosthetic heart valve market. As per estimates, over 16 million people suffer from valve diseases in the U.S. alone. The growing prevalence of obesity and diabetes which are major risk factors for developing valve defects supplement the market growth. Furthermore, introduction of technologically advanced, minimally invasive transcatheter heart valves as an alternative to conventional open-heart surgeries is gradually gaining adoption, bolstering the market revenues. However, prohibitively high costs associated with valve replacement surgeries limits widespread adoption, especially in developing regions. Stringent regulatory guidelines for new product approvals also impacts the market adversely. But ongoing R&D for developing affordable devices and enhanced technologies presents significant opportunities for prosthetic heart valve manufacturers over coming years.

Key Features of the Study:

  • This report provides an in-depth analysis of the global prosthetic heart valve market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global prosthetic heart valve market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study includes Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife Inc., Braile Biomedica, Colibri Heart Valve LLC, JenaValve Technology , TTK Healthcare Limited , Lepu Medical Technology Co. Ltd , Foldax, Inc. , Symetis SA , On-X Life Technologies, and Braile Biomedica
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global prosthetic heart valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prosthetic heart valve market

Market Segmentation

  • Valve Type:
    • Mechanical Valves
    • Tissue Valves
    • Transcatheter Valves
  • Position Type:
    • Aortic Valve
    • Mitral Valve
    • Others
  • End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Catheterization Laboratory
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Edwards Lifesciences Corporation
    • Medtronic plc.
    • Boston Scientific Corporation
    • Abbott Laboratories
    • LivaNova PLC
    • CryoLife Inc.
    • Braile Biomedica
    • Colibri Heart Valve LLC
    • JenaValve Technology Inc.
    • TTK Healthcare Limited
    • Lepu Medical Technology Co. Ltd
    • Foldax, Inc.
    • Symetis SA
    • On-X Life Technologies
    • Braile Biomedica

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Position Type
    • Market Snapshot, By Valve Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
    • Market Scenario - Conservative, Likely, Opportunistic
  • Market Opportunity Map

3. Key Insights

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancements
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals
  • Identification of Key Players in Each Region
  • Regulatory Scenario
  • Pricing Analysis
  • COVID-19 Impact Analysis
  • Epidemiology
  • Healthcare Spending, by Country
  • Reimbursement Scenario
  • Distributors Landscape
  • Brand Mapping
  • Competitive Snapshot
  • Company Positioning Analysis
  • Heat Map Analysis

4. Global Prosthetic Heart Valve Market, By Position Type, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Aortic Valve, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Mitral Valve, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

5. Global Prosthetic Heart Valve Market, By Valve Type, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Mechanical Valves, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Tissue Valves, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Transcatheter Valves, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

6. Global Prosthetic Heart Valve Market, By End User, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Hospitals, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Ambulatory Surgical Centers, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Catheterization Laboratory, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

7. Global Prosthetic Heart Valve Market, By Region, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Billion)
    • Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Billion)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Asean
      • Rest Of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • GCC
      • Israel
      • Rest Of The Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Billion)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Competitive Snapshot
  • What Market Participants are Saying?
  • Competitive Dashboard
  • Company Market Share Analysis, 2025 - Global

9. Company Profiles - Global Prosthetic Heart Valve Market

  • Edwards Lifesciences Corporation*
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Medtronic plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova PLC
  • CryoLife Inc.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • JenaValve Technology Inc.
  • TTK Healthcare Limited
  • Lepu Medical Technology Co. Ltd
  • Foldax, Inc.
  • Symetis SA
  • On-X Life Technologies
  • Braile Biomedica

10. Wheel of Fortune

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact